Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Michael Kazim, MD
Healthcare Professional Professor
Ophthalmology and Surgery Harkness Eye Institute
Columbia University Medical Center
635 West 165th Street
New York, New York, United States
Michael Kazim is Clinical Professor of ophthalmology and surgery at the Harkness Eye Institute – Columbia University Medical Center. He completed medical school, an internship in general surgery and residency in ophthalmology at Columbia before moving to University of Pennsylvania- Scheie Eye Institute/Children’s Hospital of Philadelphia for fellowship training in oculoplastic surgery and craniofacial ophthalmology. He then took a second fellowship in Pittsburgh in orbital surgery and neuro-ophthalmology. He subsequently returned to the Harkness Eye Institute where he has practiced since 1990.
Dr. Kazim is world recognized for his work in the field of orbital disease including the management of complex orbital tumors and thyroid eye disease. He is a member of the International Orbit Society, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), American Academy of Ophthalmology (AAO), American College of Surgeons and is a founding member and first President of the International Thyroid Eye Disease Society (ITEDS).
He is currently the chief investigator for several clinical studies for thyroid eye disease. He has published over 100 article and book chapters, and is an editor or reviewer for a dozen peer-review journals. His clinical interests have fostered the development of multiple new surgical procedures and devices.
Representative Publications:
Prominent Proptosis in Childhood Thyroid Eye Disease
Levator Excursion as a Predictor of Both Eyelid Lag and Lagophthalmos in Thyroid Eye Disease
Modified Full-Thickness Blepharotomy for Treatment of Thyroid Eye Disease
Reactivation of Thyroid Eye Disease Following Extraocular Muscle Surgery
Related Content
-
Teprotumumab, an Insulin-Like Growth Factor-1 Receptor Antagonist Antibody, in the Treatment of Active Thyroid eye D...Thyroid eye disease is a disabling autoi...
-
Radioiodine-Associated Exacerbation of Graves’ Orbitopathy in the Japanese Population: Randomized Prospective ...Context: Exacerbation of Graves' orbito...
-
Advances in the Pharmacological Treatment of Graves’ OrbitopathyGraves' orbitopathy has a deteriorating ...
-
¿Qué Es La Enfermedad De Graves?¿De Qué Manera Afecta A Los Ojos La En...
-
Does Treatment of Graves’ Disease Modify The Long-Term Course of Graves’ Orbitopathy?Introduction: Graves’ orbitopathy (GO...
-
Effects of Treatment Modalities for Graves’ Hyperthyroidism on Graves’ Orbitopathy: A 2015 Italian Society of En...Graves’ disease is the most frequent f...
-
Clinical Implications of Immunoglobulin G4 to Graves’ OphthalmopathyBackground: This study aimed to explore...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.